Related references
Note: Only part of the references are listed.Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG(2) cells
Haiyun Sun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
F. Thomas Wunderlich et al.
CELL METABOLISM (2010)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
Human IL6 enhances leptin action in mice
M. Sadagurski et al.
DIABETOLOGIA (2010)
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
A. Nerstedt et al.
DIABETOLOGIA (2010)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Bei B. Zhang et al.
CELL METABOLISM (2009)
Activation of AMP-Activated Protein Kinase by Interleukin-6 in Rat Skeletal Muscle Association With Changes in cAMP, Energy State, and Endogenous Fuel Mobilization
Meghan Kelly et al.
DIABETES (2009)
Fenofibrate Differentially Regulates Plasminogen Activator Inhibitor-1 Gene Expression via Adenosine Monophosphate-Activated Protein Kinase-Dependent Induction of Orphan Nuclear Receptor Small Heterodimer Partner
Dipanjan Chanda et al.
HEPATOLOGY (2009)
Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA
Sebastien Banzet et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Hepatocyte Growth Factor Family Negatively Regulates Hepatic Gluconeogenesis via Induction of Orphan Nuclear Receptor Small Heterodimer Partner in Primary Hepatocytes
Dipanjan Chanda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment
Christine Carter-Kent et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme
Dipanjan Chanda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner
Dipanjan Chanda et al.
ENDOCRINE JOURNAL (2008)
Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats
Anna G. Holmes et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
Herbert Tilg et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP
Yong Deuk Kim et al.
DIABETES (2008)
Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells
Johanna L. Barclay et al.
MOLECULAR ENDOCRINOLOGY (2007)
The dual function of hepatic SOCS3 in insulin resistance in vivo
Takehiro Torisu et al.
GENES TO CELLS (2007)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Interleukin-6 and diabetes - The good, the bad, or the indifferent?
OP Kristiansen et al.
DIABETES (2005)
Analysis of SOCS-3 promoter responses to interferon γ
L Gatto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
K Ueki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
K Ueki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes - Preservation of cytokine signaling during fever
M Shah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
Share Paper
